Kura Oncology
KURA
KURA
165 hedge funds and large institutions have $1.72B invested in Kura Oncology in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 54 increasing their positions, 48 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
+25
Holders Change %
+17.86%
% of All Funds
2.39%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
40
Increased
54
Reduced
48
Closed
15
Calls
$19.8M
Puts
$3.59M
Net Calls
+$16.2M
Net Calls Change
+$15.7M
Top Buyers
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
$66.9M |
| 2 |
State Street
Boston,
Massachusetts
|
$89.6M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
$21.3M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
$82.1M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
$15.6M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
$102M |
| 2 |
Morgan Stanley
New York
|
$29M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
$10.7M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$393K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
$29.1M |
